Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 12/20 | 0.51 |
| ▸ | NPY1R | P25929 | 7/20 | 0.51 |
| ▸ | NPY2R | P49146 | 5/20 | 0.51 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.51 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.43 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.43 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.43 |
| ▸ | FURIN | P09958 | 3/20 | 0.40 |
| ▸ | NMT2 | O60551 | 1/20 | 0.40 |
| ▸ | NMT1 | P30419 | 1/20 | 0.40 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.40 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.40 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.38 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29378646 | 1.00 | NPY4R (0.51) | NPY4RNPY1RNPY2RNPY5RGNAI3 | |
| SCHEMBL30422560 | 1.00 | NPY4R (0.51) | NPY4RNPY1RNPY2RNPY5RGNAI3 | |
| SCHEMBL30121066 | 1.00 | NPY4R (0.51) | NPY4RNPY1RNPY2RNPY5RGNAI3 | |
| SCHEMBL8742594 | 1.00 | NPY4R (0.51) | NPY4RNPY1RNPY2RNPY5RGNAI3 | |
| SCHEMBL8742615 | 1.00 | NPY4R (0.51) | NPY4RNPY1RNPY2RNPY5RGNAI3 | |
| SCHEMBL30423395 | 1.00 | NPY4R (0.51) | NPY4RNPY1RNPY2RNPY5RGNAI3 | |
| SCHEMBL29642059 | 0.96 | NPY4R (0.48) | NPY4RNPY1RNPY2RNPY5RGNAI3 | |
| SCHEMBL10944182 | 0.95 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5RGNAI3 | |
| SCHEMBL10940273 | 0.95 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5RGNAI3 | |
| SCHEMBL10942024 | 0.95 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5RGNAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260007602-A1 | Neutral Liposomes Containing Biologically Active Agents | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2026-01-08 | — | — | US | disclosed |
| US-20250243244-A1 | CYCLIC CELL PENETRATING PEPTIDES | ENTRADA THERAPEUTICS, INC. | 2025-07-31 | — | — | US | disclosed |
| US-20250101063-A1 | POLYPEPTIDE COMPOUND AND USE THEREOF IN TREATMENT OF ENTERITIS | SICHUAN GOODDOCTOR PANXI PHARMACEUTICAL CO., LTD. (CN) | 2025-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250243244-A1 | CYCLIC CELL PENETRATING PEPTIDES | SLC47A1, SLC47A2, VIP | NPY4R 2162/4885NPY1R 1441/4885NPY2R 1575/4885 |
| US-20260007602-A1 | Neutral Liposomes Containing Biologically Active Agents | NPC1L1, MCM7, LIPA | NPY4R 1405/4885NPY1R 1569/4885NPY2R 1307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.